Institutional Ownership Kal Vista Pharmaceuticals, Inc. (KALV)
This table provides information about the institutional ownership of Kal Vista Pharmaceuticals, Inc. (KALV). We have compiled data on the 155 institutions that hold shares in the stock, with a total of 57.9 Million shares, which have been reported (via 13F filing form) to have a value of $771 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vr Adviser, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
6,728,985
shares
|
$89.6 Million
12.35% of portfolio
|
Q2 2025
Added 0.37%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
5,041,798
shares
|
$67.2 Million
2.77% of portfolio
|
Q3 2025
Added 2.02%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 14, 2025 Q3 2025 |
5,039,867
shares
|
$67.1 Million
2.57% of portfolio
|
Q3 2025
Added 3.11%
|
|
|
Suvretta Capital Management, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
4,768,712
shares
|
$63.5 Million
1.73% of portfolio
|
Q3 2025
Reduced 3.76%
|
|
|
Capital World Investors
Los Angeles, CA |
Nov 13, 2025 Q3 2025 |
3,177,587
shares
|
$42.3 Million
0.01% of portfolio
|
Q1 2025
Reduced 5.82%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,945,116
shares
|
$39.2 Million
0.0% of portfolio
|
Q2 2024
Added 21.09%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
2,501,119
shares
|
$33.3 Million
0.0% of portfolio
|
Q3 2025
Added 3.68%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2025 Q3 2025 |
2,096,223
shares
|
$27.9 Million
0.01% of portfolio
|
Q3 2025
Added 515.4%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
1,920,664
shares
|
$25.6 Million
0.12% of portfolio
|
Q2 2025
Added 18.75%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
1,800,181
shares
|
$24 Million
0.0% of portfolio
|
Q3 2025
Added 1239.44%
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Nov 14, 2025 Q3 2025 |
1,735,003
shares
|
$23.1 Million
2.62% of portfolio
|
Q3 2025
Added 155.5%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
1,575,496
shares
|
$21 Million
0.0% of portfolio
|
Q3 2025
Added 16.74%
|
|
|
Silverarc Capital Management, LLC
|
Nov 12, 2025 Q3 2025 |
1,363,378
shares
|
$18.2 Million
3.39% of portfolio
|
Q3 2025
Reduced 25.59%
|
|
|
Emerald Advisers, LLC
|
Oct 30, 2025 Q3 2025 |
1,351,254
shares
|
$18 Million
0.56% of portfolio
|
Q3 2025
Added 30.17%
|
|
|
Octagon Capital Advisors LP
New York, NY |
Nov 14, 2025 Q3 2025 |
1,273,333
shares
|
$17 Million
5.01% of portfolio
|
Q2 2025
Reduced 7.06%
|
|
|
Schroder Investment Management Group
London, X0 |
Nov 12, 2025 Q3 2025 |
1,158,457
shares
|
$15.4 Million
0.01% of portfolio
|
Q3 2025
Added 108.75%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
928,671
shares
|
$12.4 Million
0.0% of portfolio
|
Q3 2025
Reduced 1.33%
|
|
|
Emerald Mutual Fund Advisers Trust
|
Oct 30, 2025 Q3 2025 |
917,975
shares
|
$12.2 Million
0.63% of portfolio
|
Q3 2025
Added 19.38%
|
|
|
Vestal Point Capital, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
750,000
shares
|
$9.99 Million
0.41% of portfolio
|
Q3 2025
Reduced 83.96%
|
|
|
Freestone Grove Partners LP
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
704,448
shares
|
$9.38 Million
0.06% of portfolio
|
Q3 2025
New holding
|
|
|
Sio Capital Management, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
683,819
shares
|
$9.11 Million
2.86% of portfolio
|
Q3 2025
New holding
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
Nov 14, 2025 Q3 2025 |
606,171
shares
|
$8.07 Million
0.62% of portfolio
|
Q3 2025
New holding
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
577,904
shares
|
$7.7 Million
0.0% of portfolio
|
Q3 2025
Added 242.11%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
564,856
shares
|
$7.52 Million
0.0% of portfolio
|
Q3 2025
Added 135.72%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
454,148
shares
|
$6.05 Million
0.0% of portfolio
|
Q3 2025
Added 66.44%
|
|